(NYSE:EDR), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Endeavor To Contact Him Directly To Discuss Their Options If you sold Endeavor Class A common stock between January 15, 2025 and March 24, 2025 and would like to discuss your legal rights, call Faruqi & […]

KLAR CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Klarna Group plc (KLAR) Investors of Securities Class Action Deadline on February 20, 2026 GlobeNewswire February 15, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Klarna To Contact Him Directly To Discuss Their Options If

EDR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Endeavor Group (EDR) Investors of Securities Class Action Deadline on March 18, 2026 GlobeNewswire February 15, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Endeavor To Contact Him Directly To Discuss Their Options If you sold

(NASDAQ:WLTH), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Wealthfront To Contact Him Directly To Discuss Their Options If you suffered significant losses in Wealthfront stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292

WLTH SECURITIES ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Wealthfront GlobeNewswire February 15, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Wealthfront To Contact Him Directly To Discuss Their Options If you suffered significant losses in Wealthfront stock or options

(NasdaqGM:AQST), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Aquestive Therapeutics To Contact Him Directly To Discuss Their Options If you suffered significant losses in Aquestive Therapeutics stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly

AQST SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics GlobeNewswire February 15, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Aquestive Therapeutics To Contact Him Directly To Discuss Their Options If you suffered significant losses in Aquestive Therapeutics

(NYSE:ARDT), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Ardent To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Ardent between July 18, 2024 and November 12, 2025 and would like to discuss your legal rights, call Faruqi &

ARDT DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ardent Health (ARDT) Investors of Securities Class Action Deadline on March 9, 2026 GlobeNewswire February 15, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Ardent To Contact Him Directly To Discuss Their Options If you suffered

(NASDAQ:PLUG), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Plug Power To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Plug Power between January 17, 2025 and November 13, 2025 and would like to discuss your legal rights, call